Advertisement

Neuroethics

, Volume 3, Issue 1, pp 1–4 | Cite as

Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs?

Ethics Blind Spots in Current Debates
  • Eric RacineEmail author
  • Cynthia Forlini
Brief Communication

Abstract

The prospects of enhancing cognitive or motor functions using neuroscience in otherwise healthy individuals has attracted considerable attention and interest in neuroethics (Farah et al., Nature Reviews Neuroscience 5:421–425, 2004; Glannon Journal of Medical Ethics 32:74–78, 2006). The use of stimulants is one of the areas which has propelled the discussion on the potential for neuroscience to yield cognition-enhancing products. However, we have found in our review of the literature that the paradigms used to discuss the non-medical use of stimulant drugs prescribed for attention deficit/hyperactivity disorder (ADHD) vary considerably. In this brief communication, we identify three common paradigms—prescription drug abuse, cognitive enhancement, and lifestyle use of pharmaceuticals—and briefly highlight how divergences between paradigms create important “ethics blind spots”.

Keywords

Neuroethics Enhancement Prescription drug misuse Lifestyle drugs Public health 

Notes

Acknowledgments

We would like to acknowledge the support of the International Institute for Research in Ethics and Biomedicine, the Canadian Institutes of Health Research, the Social Sciences and Humanities Research Council of Canada, and the Institut de recherches cliniques de Montréal. Thanks to Nicole Palmour, Dr. Emily Bell, and Dr. David Bouvier. The authors report no conflicts of interest

References

  1. 1.
    Anonymous. 2007. Enhancing, not cheating. Nature 450: 320.Google Scholar
  2. 2.
    British Medical Association. 2007. Boosting your brainpower: Ethical aspects of cognitive enhancement. 42. London, UK: British Medical Association.Google Scholar
  3. 3.
    Chatterjee, A. 2007. Cosmetic neurology and cosmetic surgery: parallels, predictions, and challenges. Cambridge Quarterly of Healthcare Ethics 16: 129–137.CrossRefGoogle Scholar
  4. 4.
    Farah, M.J., J. Illes, R. Cook-Deegan, H. Gardner, E. Kandel, P. King, E. Parens, B. Sahakian, and P.R. Wolpe. 2004. Neurocognitive enhancement: what can we do and what should we do? Nature Reviews Neuroscience 5: 421–425.CrossRefGoogle Scholar
  5. 5.
    Garreau, J. 2006. ‘Smart pills’ are on the rise. But is taking them wise? The Washington Post. June 11: D01.Google Scholar
  6. 6.
    Glannon, W. 2006. Psychopharmacology and memory. Journal of Medical Ethics 32: 74–78.CrossRefGoogle Scholar
  7. 7.
    Hall, K.M., M.M. Irwin, K.A. Bowman, W. Frankenberger, D.C. Jewett. 2005. Illicit use of prescribed stimulant medication among college students. Journal of American College Health 53: 167–174.CrossRefGoogle Scholar
  8. 8.
    Khan, M. 2003. Study drugs draw concern. The Miami Herald. July 6: 1BR.Google Scholar
  9. 9.
    Laurance, J. 2003. Abuse hits students looking for an exam kick. The Independent. August 26: 5.Google Scholar
  10. 10.
    Low, K.G., A.E. Gendaszek. 2002. Illicit use of psychostimulants among college students: a preliminary study. Psychology, Health & Medicine 7: 283–287.CrossRefGoogle Scholar
  11. 11.
    Maher, B. 2008. Poll results: look who’s doping. Nature 452: 674–675.CrossRefGoogle Scholar
  12. 12.
    National Institute on Drug Abuse. 2005. Prescription drugs: Abuse and addiction. Research report series. National Institute on Drug Abuse: 12 p.Google Scholar
  13. 13.
    Phillips, S. 2006. An espresso at three in the morning is just so last year. The Times Higher Education Supplement. March 10: 18.Google Scholar
  14. 14.
    President’s Council on Bioethics. 2003. Beyond therapy. President’s Council on Bioethics/Harper Collins: Washington, D.C., 328 p.Google Scholar
  15. 15.
    Prudhomme White, B., K.A. Becker-Blease, K. Grace-Bishop. 2006. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. Journal of American College Health 54: 261–268.Google Scholar
  16. 16.
    Teter, C.J., S.E. McCabe, J.A. Cranford, C.J. Boyd, S.K. Guthrie. 2005. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health 53: 253–262.CrossRefGoogle Scholar
  17. 17.
    Teter, C.J., S.E. McCabe, K. LaGrange, J.A. Cranford, C.J. Boyd. 2006. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26: 1501–1510.CrossRefGoogle Scholar
  18. 18.
    Wilens, T.E., L.A. Adler, J. Adams, et al. 2008. Misuse and diversion of stimulants prescribes for ADHD: a systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry 47: 21–31.CrossRefGoogle Scholar
  19. 19.
    Zernike, K. 2005. The difference between steroids and Ritalin is. The New York Times. March 20: 3.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.Institut de recherches cliniques de MontréalMontrealCanada
  2. 2.Université de MontréalMontrealCanada
  3. 3.McGill UniversityMontrealCanada

Personalised recommendations